The reduction of PPAR-γ in T2DM patients may contribute to dysregulation in insulin sensitivity and promote inflammatory processes by virtue of its role, as reported to inhibit NF-κB activities [37]. Here, PPARG is linked to type 2 diabetes mellitus.